Otsuka (OTCMKTS:OTSKF – Get Free Report) is expected to announce its resultson Tuesday, April 28th. Analysts expect the company to announce earnings of $0.8290 per share and revenue of $3.6694 billion for the quarter.
Otsuka Price Performance
Shares of OTSKF opened at $69.70 on Tuesday. Otsuka has a 1-year low of $44.40 and a 1-year high of $72.22. The company’s fifty day moving average price is $68.48 and its 200-day moving average price is $61.39.
About Otsuka
Otsuka Holdings Co, Ltd., trading on OTC markets as OTSKF, is a global healthcare company headquartered in Tokyo, Japan. Established in 1964 as a research-driven pharmaceutical firm, Otsuka has since evolved into a diversified holding company overseeing operations in pharmaceuticals, nutraceuticals and consumer products. The company operates through a network of subsidiaries, including Otsuka Pharmaceutical Co, Ltd., Otsuka America Pharmaceutical, Inc, and Otsuka Europe, each focusing on drug development, manufacturing and distribution.
In its pharmaceutical division, Otsuka is best known for discovering and commercializing treatments in areas such as psychiatry, oncology and nephrology.
Recommended Stories
Receive News & Ratings for Otsuka Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Otsuka and related companies with MarketBeat.com's FREE daily email newsletter.
